Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cytek Biosciences Inc
(NQ:
CTKB
)
5.395
-0.015 (-0.28%)
Streaming Delayed Price
Updated: 1:37 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cytek Biosciences Inc
< Previous
1
2
3
Next >
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Misses Revenue for Q2 2024
August 06, 2024
CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
CTKB Stock Earnings: Cytek Biosciences Misses EPS, Beats Revenue for Q1 2024
May 08, 2024
CTKB stock results show that Cytek Biosciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
CTKB Stock Earnings: Cytek Biosciences Beats Revenue for Q4 2023
March 27, 2024
CTKB stock results show that Cytek Biosciences beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday
March 04, 2024
U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cytek's Full Spectrum Technology Stands Out In Cell Analysis Market, Bullish Analyst Says
December 14, 2023
Stephens initiated coverage on Cytek Biosciences Inc (NASDAQ: CTKB), a manufacturer and supplier of flow cytometry products and services.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
The Latest Analyst Ratings for Cytek Biosciences
December 14, 2023
Via
Benzinga
Why Shares of Cytek Biosciences Dropped This Week
May 12, 2023
Cytek grew revenue and losses in the first quarter.
Via
The Motley Fool
Where Cytek Biosciences Stands With Analysts
May 10, 2023
Via
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 08, 2023
Via
Benzinga
Recap: Cytek Biosciences Q1 Earnings
May 09, 2023
Via
Benzinga
Cytek Biosciences Acquires Flow Cytometry & Imaging Business From DiaSorin
February 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 07, 2023
Via
Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Cytek Biosciences: Here's What You Need To Know
October 24, 2023
Via
Benzinga
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via
Benzinga
Cytek Biosciences Earnings Perspective: Return On Capital Employed
December 15, 2022
Via
Benzinga
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
October 17, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
July 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 10, 2023
Via
Benzinga
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 10, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday.
Via
Benzinga
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 26, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
January 10, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
December 15, 2022
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Earnings Outlook For Cytek Biosciences
November 08, 2022
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Cytek...
Via
Benzinga
Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
October 06, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know
August 18, 2022
Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...
Via
Benzinga
Analyst Ratings for Cytek Biosciences
August 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.